- Home
- EFSC vs SUPN Comparison
EFSC vs SUPN Comparison
Compare EFSC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- SUPN
- Stock Information
- Founded
- EFSC 1988
- SUPN 2005
- Country
- EFSC United States
- SUPN United States
- Employees
- EFSC N/A
- SUPN N/A
- Industry
- EFSC Major Banks
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- SUPN Health Care
- Exchange
- EFSC Nasdaq
- SUPN Nasdaq
- Market Cap
- EFSC 2.1B
- SUPN 2.1B
- IPO Year
- EFSC 1999
- SUPN 2012
- Fundamental
- Price
- EFSC $57.58
- SUPN $38.58
- Analyst Decision
- EFSC Strong Buy
- SUPN Hold
- Analyst Count
- EFSC 4
- SUPN 1
- Target Price
- EFSC $56.50
- SUPN $36.00
- AVG Volume (30 Days)
- EFSC 145.5K
- SUPN 361.3K
- Earning Date
- EFSC 01-27-2025
- SUPN 02-25-2025
- Dividend Yield
- EFSC 1.94%
- SUPN N/A
- EPS Growth
- EFSC N/A
- SUPN 130.79
- EPS
- EFSC 4.72
- SUPN 1.07
- Revenue
- EFSC $591,631,000.00
- SUPN $651,972,000.00
- Revenue This Year
- EFSC N/A
- SUPN $7.77
- Revenue Next Year
- EFSC $0.15
- SUPN N/A
- P/E Ratio
- EFSC $12.24
- SUPN $36.07
- Revenue Growth
- EFSC N/A
- SUPN 6.79
- 52 Week Low
- EFSC $37.28
- SUPN $25.53
- 52 Week High
- EFSC $63.13
- SUPN $39.37
- Technical
- Relative Strength Index (RSI)
- EFSC 53.73
- SUPN 63.92
- Support Level
- EFSC $55.80
- SUPN $37.27
- Resistance Level
- EFSC $58.62
- SUPN $38.68
- Average True Range (ATR)
- EFSC 1.48
- SUPN 1.01
- MACD
- EFSC 0.29
- SUPN 0.12
- Stochastic Oscillator
- EFSC 80.27
- SUPN 96.61
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.